|
|
|
|
LEADER |
00000nam a2200000 a 4500 |
001 |
5eafc168-1f44-4add-ad16-c42a4929e12b |
005 |
20240705000000.0 |
008 |
970210s1997 pau b 000 0 eng d |
020 |
|
|
|a 0397584431
|
035 |
|
|
|a (OCoLC)36363074
|
040 |
|
|
|a SWT
|c SWT
|d MnU-B
|
049 |
|
|
|a UMMA
|
050 |
|
4 |
|a RC271.A35
|
060 |
|
0 |
|a QZ 267
|b In8a 1997
|
111 |
2 |
|
|a International Conference on the Adjuvant Therapy of Cancer
|n (8th :
|d 1996 :
|c Scottsdale, Ariz.)
|
245 |
1 |
0 |
|a Adjuvant therapy of cancer VIII :
|b proceedings of the Eighth International Conference on the Adjuvant Therapy of Cancer, Scottsdale, Arizona, March, 1996 /
|c edited by Sydney E. Salmon.
|
260 |
|
|
|a Philadelphia :
|b Lippincott,
|c ©1997.
|
300 |
|
|
|a xviii, 298 pages :
|b illustrations ;
|c 24 cm
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
500 |
|
|
|a Eighth conference held March 13-16, 1996.
|
504 |
|
|
|a Includes bibliographical references.
|
650 |
|
0 |
|a Cancer
|x Adjuvant treatment
|v Congresses
|
650 |
|
2 |
|a Adjuvants, Immunologic
|x therapeutic use
|
650 |
|
2 |
|a Adjuvants, Pharmaceutic
|x therapeutic use
|
650 |
|
2 |
|a Neoplasms
|x drug therapy
|
655 |
|
2 |
|a Congress
|
700 |
1 |
|
|a Salmon, S. E.
|q (Sydney E.),
|d 1936-
|
740 |
0 |
|
|a Adjuvant therapy of cancer eight.
|
740 |
0 |
|
|a Adjuvant therapy of cancer 8.
|
999 |
1 |
0 |
|i 5eafc168-1f44-4add-ad16-c42a4929e12b
|l 9955915670001701
|s US-MNU
|m adjuvant_therapy_of_cancer_viiiproceedings_of_the_eighth_international_____1997_______lippia________________________________________international_confer_______________p
|
999 |
1 |
1 |
|l 9955915670001701
|s ISIL:US-MNU
|i University of Minnesota
|t BKS
|a ZMLACGENX
|d Shelving Control Number
|b 31951M013396570
|x BOOK
|y 23490335030001701
|p LOANABLE
|
999 |
1 |
1 |
|l 9955915670001701
|s ISIL:US-MNU
|i University of Minnesota
|t BKS
|a TBIOMGENX
|c QZ267 I605 1996a
|d NLM
|b 31951D014933123
|x BOOK
|y 23490335080001701
|p UNLOANABLE
|